News

By mhspitzer on
January 24, 2017

Our newest paper is now officially out in Cell

 
Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Spitzer MH, Carmi Y, Reticker-Flynn NE, Kwek SS, Madhireddy D, Martins MM, Gherardini PF, Prestwood TR, Chabon J, Bendall SC, Fong L, Nolan GP, Engleman EG.
Cell. 2017 Jan 10. pii: S0092-8674(16)31738-X. doi: 10.1016/j.cell.2016.12.022. [Epub ahead of print]

PMID: 28111070

 

A link to the paper can be found here: http://www.cell.com/cell/abstract/S0092-8674(16)31738-X

 

Check out the UCSF press release here: https://www.ucsf.edu/news/2017/01/405581/successful-immunotherapy-requires-system-wide-immune-response

 

 

By mhspitzer on
October 04, 2016

The Office of the Director at the NIH has announced a new series of High-Risk High-Reward research grants. Among those funded, the Spitzer lab recevied one of the Director's Early Independnce Awards to support our efforts to understand how cancer development impacts the immune system, with the goal of identifying elements of the immune system that are optimal for targeting by cancer immunotherapies. Read more about the awards here:

http://www.ucsf.edu/news/2016/10/404461/seven-ucsf-scientists-receive-nih-blue-sky-research-awards

https://commonfund.nih.gov/earlyindependence/Recipients16